Income, education, and inflammation: Differential associations in a national probability sample (the midus study)

Psychosomatic Medicine

Volumn 72, Issue 3, 2010, Pages 290-300

  Friedman, Elliot M ^a   Herd, Pamela ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Education; Income; Inflammation

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; INTERLEUKIN 6;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; EDUCATIONAL STATUS; FEMALE; HEALTH SURVEY; HOSPITALIZATION; HOUSEHOLD; HUMAN; INCOME; INFLAMMATION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MENTAL CAPACITY; PRIORITY JOURNAL; PROBABILITY; QUESTIONNAIRE; SOCIAL STATUS;

EID: 77951427944     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0b013e3181cfe4c2     Document Type: Article

References (73)

1. Crimmins EM, Saito Y. Trends in healthy life expectancy in the United States, 1970-1990: gender, racial, and educational differences. Soc Sci Med 2001;52:1629-1641
2. Rogot E, Sorlie PD, Johnson NJ. Life expectancy by employment status, income, and education in the National Longitudinal Mortality Study. Public Health Rep 1992;107:457-461
3. Adler NE, Boyce T, Chesney MA, Cohen S, Folkman S, Kahn RL, Syme SL. Socioeconomic status and health. The challenge of the gradient. Am Psychol 1994;49:15-24.
4. Marmot M, Wilkinson RG. Social Determinants of Health. New York: Oxford University Press; 1999.
5. Kaplan GA, Keil JE. Socioeconomic factors and cardiovascular disease: a review of the literature. Circulation 1993;88:1973-1998
6. Cesari M, Penninx BW, Newman AB, Kritchevsky SB, Nicklas BJ, Sutton-Tyrrell K, Tracy RP, Rubin SM, Harris TB, Pahor M, Yaffe K, Lindquist K, Simonsick EM, Kritchevsky S, Launer L, Kuller L, Rubin S, Harris T. Inflammatory markers and cardiovascular disease. (The Health, Aging and Body Composition [Health ABC] Study) Am J Cardiol 2003; 92:522-528 (Pubitemid 37013402)
7. Danesh J, Lewington S, Thompson SG, Lowe GD, Collins R, Kostis JB, Wilson AC, Folsom AR, Wu K, Benderly M, Goldbourt U, Willeit J, Kiechl S, Yarnell JW, Sweetnam PM, Elwood PC, Cushman M, Psaty BM, Tracy RP, Tybjaerg-Hansen A, Haverkate F, de Maat MP, Fowkes FG, Lee AJ, Smith FB, Salomaa V, Harald K, Rasi R, Vahtera E, Jousilahti P, Pekkanen J, D'Agostino R, Kannel WB, Wilson PW, Tofler G, Arocha-Pinango CL, Rodriguez-Larralde A, Nagy E, Mijares M, Espinosa R, Rodriquez-Roa E, Ryder E, Diez-Ewald MP, Campos G, Fernandez V, Torres E, Marchioli R, Valagussa F, Rosengren A, Wil-helmsen L, Lappas G, Eriksson H, Cremer P, Nagel D, Curb JD, Rodriguez B, Yano K, Salonen JT, Nyyssonen K, Tuomainen TP, Hedblad B, Lind P, Loewel H, Koenig W, Meade TW, Cooper JA, De Stavola B, Knottenbelt C, Miller GJ, Cooper JA, Bauer KA, Rosenberg RD, Sato S, Kitamura A, Naito Y, Palosuo T, Ducimetiere P, Amouyel P, Arveiler D, Evans AE, Ferrieres J, Juhan-Vague I, Bingham A, Schulte H, Assmann G, Cantin B, Lamarche B, Despres JP, Dagenais GR, Tunstall-Pedoe H, Woodward M, Ben-Shlomo Y, Davey Smith G, Palmieri V, Yeh JL, Rudnicka A, Ridker P, Rodeghiero F, Tosetto A, Shepherd J. Plasma fibrinogen level and the risk of major cardiovascular diseases and non-vascular mortality: an individual participant meta-analysis. JAMA 2005; 294:1799-1809
8. Empana JP, Sykes DH, Luc G, Juhan-Vague I, Arveiler D, Ferrieres J, Amouyel P, Bingham A, Montaye M, Ruidavets JB, Haas B, Evans A, Jouven X, Ducimetiere P. Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men. The Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation 2005;111:2299-2305
9. Pradhan AD, Manson JE, Rossouw JE, Siscovick DS, Mouton CP, Rifai N, Wallace RB, Jackson RD, Pettinger MB, Ridker PM. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study. JAMA 2002;288:980-987
10. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-843 (Pubitemid 30165206)
11. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000;101:1767-1772
12. Vasan RS, Sullivan LM, Roubenoff R, Dinarello CA, Harris T, Benjamin EJ, Sawyer DB, Levy D, Wilson PW, D'Agostino RB. Inflammatory markers and risk of heart failure in elderly subjects without prior myo-cardial infarction: the Framingham Heart Study. Circulation 2003;107: 1486-1491 (Pubitemid 36378485)
13. Volpato S, Guralnik JM, Ferrucci L, Balfour J, Chaves P, Fried LP, Harris TB. Cardiovascular disease, interleukin-6, and risk of mortality in older women: the women's health and aging study. Circulation 2001;103: 947-953
14. Abraham J, Campbell CY, Cheema A, Gluckman TJ, Blumenthal RS, Danyi P. C-reactive protein in cardiovascular risk assessment: a review of the evidence. J Cardiometab Syndr 2007;2:119-123
15. Mitka M. Panel endorses limited role for CRP tests. JAMA 2003;289: 973-974
16. Smith GD, Hart C, Watt G, Hole D, Hawthorne V. Individual social class, area-based deprivation, cardiovascular disease risk factors, and mortality: the Renfrew and Paisley Study. J Epidemiol Community Health 1998; 52:399-405.
17. Alley DE, Seeman TE, Ki Kim J, Karlamangla A, Hu P, Crimmins EM. Socioeconomic status and C-reactive protein levels in the US population: NHANES IV. Brain Behav Immun 2006; 20:498-504
18. Ranjit N, Diez-Roux AV, Shea S, Cushman M, Ni H, Seeman T. Socioeconomic position, race/ethnicity, and inflammation in the multiethnic study of atherosclerosis. Circulation 2007;116:2383-2390
19. Lubbock LA, Goh A, Ali S, Ritchie J, Whooley MA. Relation of low socioeconomic status to C-reactive protein in patients with coronary heart disease (from the Heart and Soul Study). Am J Cardiol 2005;96:1506-1511
20. Koster A, Bosma H, Penninx BW, Newman AB, Harris TB, van Eijk JT, Kempen GI, Simonsick EM, Johnson KC, Rooks RN, Ayonayon HN, Rubin SM, Kritchevsky SB. Association of inflammatory markers with socioeconomic status. J Gerontol A Biol Sci Med Sci 2006;61:284-290
21. Gruenewald TL, Cohen S, Matthews KA, Tracy R, Seeman TE. Association of socioeconomic status with inflammation markers in black and white men and women in the Coronary Artery Risk Development in Young Adults (CARDIA) study. Soc Sci Med 2009; 69:451-459
22. Jousilahti P, Salomaa V, Rasi V, Vahtera E, Palosuo T. Association of markers of systemic inflammation, C reactive protein, serum amyloid A, and fibrinogen, with socioeconomic status. J Epidemiol Community Health 2003;57:730-733
23. Panagiotakos DB, Pitsavos CE, Chrysohoou CA, Skoumas J, Toutouza M, Belegrinos D, Toutouzas PK, Stefanadis C. The association between educational status and risk factors related to cardiovascular disease in healthy individuals: The ATTICA study. Ann Epidemiol 2004;14: 188-194
24. Steinvil A, Shirom A, Melamed S, Toker S, Justo D, Saar N, Shapira I, Berliner S, Rogowski O. Relation of educational level to inflammation-sensitive biomarker level. Am J Cardiol 2008;102:1034-1039
25. Owen N, Poulton T, Hay FC, Mohamed-Ali V, Steptoe A. Socioeco-nomic status, C-reactive protein, immune factors, and responses to acute mental stress. Brain Behav Immun 2003;17:286-295
26. Braveman PA, Cubbin C, Egerter S, Chideya S, Marchi KS, Metzler M, Posner S. Socioeconomic status in health research: one size does not fit all. JAMA 2005;294:2879-2888
27. Herd P, Goesling B, House JS. Socioeconomic position and health: the differential effects of education versus income on the onset versus progression of health problems. J Health Soc Behav 2007;48:223-238
28. Backlund E, Sorlie P, Johnson N. The shape of the relationship between income and mortality in the United States: evidence from the National Longitudinal Mortality Study. Ann Epidemiol 1996;6:12-23.
29. Bassuk S, Berkman L, Amick B. Socioeconomic status and mortality among the elderly: findings from four communities. Am J Epidemiol 2002;155:520-533
30. Benzeval M, Judge K, Shouls S. Understanding the relationship between income and health: how much can be gleaned from cross-sectional data? Soc Policy Admin 2001;35:376-396
31. Ellison G. Letting the genie out of the bottle? Challenges facing the relative income hypothesis. Soc Sci Med 2002;54:561-576
32. House J, Kessler R, Herzog A. Age, socioeconomic status and health. Milbank Q 1990;68:383-411.
33. House J, Lepkowski J, Kinney A, Mero R, Kessler R, Herzog A. The social stratification of aging and health. J Health Soc Behav 1994;35: 213-234
34. Martikainen P, Makela S, Koskinen S, Valkonen T. Income differences in mortality: a register-based follow-up study of three million men and women. Int J Epidemiol 2001;30:1397-1405
35. McDonough P, Duncan G, Williams D, House J. Income dynamics and adult mortality in the United States, 1972 through 1989. Am J Pub Health 1997;87:1476-1483
36. Norris J, van der Laan M, Lane S, Anderson J, Block G. Nonlinearity in demographics and behavioral determinants of morbidity. Health Serv Res 2003;38:1791-1818
37. Cutler D, Lleras-Muney A: Education and health. In: Schoeni R, House J, Kaplan G, Pollack H, editors. The Effects of Social and Economic Policy on Health. New York: Russell Sage; 2008.
38. Mirowsky J, Ross C. Education, Social Status, and Health. New York: Gruyter; 2003.
39. Ross CE, Mirowsky J. Refining the association between education and health: the effects of quantity, credential, and selectivity. Demography 1999;36:445-460
40. Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochem J 1990;265:621-636
41. Moshage H. Cytokines and the hepatic acute phase response. J Pathol 1997;181:257-266
42. Volanakis JE. Human C-reactive protein: expression, structure, and function. Mol Immunol 2001;38:189-197
43. Ganapathi MK, Rzewnicki D, Samols D, Jiang SL, Kushner I. Effect of combinations of cytokines and hormones on synthesis of serum amyloid A and C-reactive protein in Hep 3B cells. J Immunol 1991;147:1261-1265
44. Kritchevsky SB, Cesari M, Pahor M. Inflammatory markers and cardiovascular health in older adults. Cardiovasc Res 2005;66:265-275
45. Brim OG, Ryff CD, Kessler RC. How Healthy Are We? A National Study of Well-Being at Mid-Life. Chicago: University of Chicago Press; 2004.
46. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr, Taubert K, Tracy RP, Vinicor F. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499-511.
47. Fliser D, Buchholz K, Haller H. Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflam-mation. Circulation 2004;110:1103-1107
48. Tatli E, Kurum T. A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy. Can J Cardiol 2005;21: 344-348
49. Jain MK, Ridker PM. Anti-inflammatory effects of statins: clinical evidence and basic mechanisms. Nat Rev Drug Discov 2005;4:977-987
50. Kenis G, Maes M. Effects of antidepressants on the production of cytokines. Int J Neuropsychopharmacol 2002;5:401-412
51. Ridker PM, Hennekens CH, Rifai N, Buring JE, Manson JE. Hormone replacement therapy and increased plasma concentration of C-reactive protein. Circulation 1999;100:713-716 (Pubitemid 29383640)
52. Silvestri A, Gebara O, Vitale C, Wajngarten M, Leonardo F, Ramires JA, Fini M, Mercuro G, Rosano GM. Increased levels of C-reactive protein after oral hormone replacement therapy may not be related to an increased inflammatory response. Circulation 2003;107:3165-3169
53. Lakoski SG, Cushman M, Criqui M, Rundek T, Blumenthal RS, D'Agostino RB Jr, Herrington DM. Gender and C-reactive protein: data from the Multiethnic Study of Atherosclerosis (MESA) cohort. Am Heart J 2006;152:593-598
54. Ball K, Crawford D. Socioeconomic status and weight change in adults: a review. Soc Sci Med 2005;60:1987-2010.
55. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 1986;51:1173-1182
56. Goldman DP, Smith JP. Can patient self-management help explain the SES health gradient? Proc Natl Acad Sci USA 2002;99:10929-10934
57. House J. Understanding social factors and inequalities in health: 20th century progress and 21st century prospects. J Health Soc Behav 2002; 43:125-142
58. McLaren L. Socioeconomic status and obesity. Epidemiol Rev 2007;29: 29-48.
59. Marmot MG. Understanding social inequalities in health. Perspect Biol Med 2003;46:S9-23.
60. Dowd JB, Aiello AE, Alley DE. Socioeconomic disparities in the sero-prevalence of cytomegalovirus infection in the US population: NHANES III. Epidemiol Infect 2009;137:58-65.
61. Zajacova A, Dowd JB, Aiello AE. Socioeconomic and race/ethnic patterns in persistent infection burden among U.S. adults. J Gerontol A Biol Sci Med Sci 2009;64:272-279
62. Taylor SE, Seeman TE. Psychosocial resources and the SES-health relationship. Ann N Y Acad Sci 1999;896:210-225
63. Grzywacz JG, Almeida DM, Neupert SD, Ettner SL. Socioeconomic status and health: a micro-level analysis of exposure and vulnerability to daily stressors. J Health Soc Behav 2004;45:1-16.
64. Almeida DM, Neupert SD, Banks SR, Serido J. Do daily stress processes account for socioeconomic health disparities? J Gerontol B Psychol Sci Soc Sci 2005;60:34-39
65. Brydon L, Edwards S, Mohamed-Ali V, Steptoe A. Socioeconomic status and stress-induced increases in interleukin-6. Brain Behav Immun 2004; 18:281-290
66. Kiecolt-Glaser JK, Preacher KJ, MacCallum RC, Atkinson C, Malarkey WB, Glaser R. Chronic stress and age-related increases in the proinflam-matory cytokine IL-6. Proc Natl Acad Sci USA 2003;100:9090-9095
67. Robles TF, Glaser R, Kiecolt-Glaser JK. Out of balance: a new look at chronic stress, depression, and immunity. Curr Dir Psych Sci 2005;14: 111-115
68. Steptoe A, Kunz-Ebrecht S, Owen N, Feldman PJ, Rumley A, Lowe GD, Marmot M. Influence of socioeconomic status and job control on plasma fibrinogen responses to acute mental stress. Psychosom Med 2003;65: 137-144
69. Rose-John S, Scheller J, Elson G, Jones SA. Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer. J Leukoc Biol 2006;80:227-236
70. McCarty MF. Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: down-regulation with essential fatty acids, ethanol and pentoxi-fylline. Med Hypotheses 1999;52:465-477
71. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, Klein S, Coppack SW. Subcutaneous adipose tissue releases interleu-kin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 1997;82:4196-4200
72. Mortensen RF. C-reactive protein, inflammation, and innate immunity. Immunol Res 2001;24:163-176
73. Tennent GA, Brennan SO, Stangou AJ, O'Grady J, Hawkins PN, Pepys MB. Human plasma fibrinogen is synthesized in the liver. Blood 2007; 109:1971-1974